Investment History
OUR HISTORY
Our journey began in 2012, with our primary investment into Elite Residence in Dubai. From there we have gone from strength to strength and expanded our portfolio into all kinds of life sciences, technology, pharmaceutical and real estate investment opportunities.
2012
January 1st
Luxury residential tower in Dubai Marina.
2013
January 1st
One of our key bio-tech investments which we exited in 2019.
2019
January 1st
A fund created to develop land in Berlin for real estate development by Deutsche Landentwicklung Holding AG.
June 1st
A Swiss clinical-stage biotechnology company with an encapsulated cellular cancer immunotherapy.
2020
January 1st
A Med Tech Club Deal – a fund for musculoskeletal opportunities.
July 14th
Medical curved implants for curved bones within the body.
September 15th
Orthopaedic surgery instrumentation.
October 28th
A neuromodulation company based in the USA.
2021
January 11th
A next-generation asset management company.
January 18th
Orthopaedic surgery instrumentation.
February 1st
Land development fund in Berlin.
April 29th
Orthopaedic surgery instrumentation.
June 1st
Second tranch investment.
June 13th
Investment in shares.
June 21st
Participation in the second closing of Series B-1 shares.
September 27th
New capital contribution.
October 1st
Committed to investing in NEMO V, spreading over four years.
2022
January 16th
Participation in the milestone closing of Series B-1 shares.
February 1st
Participating in NEMO V with Garuda Therapeutics and Magnolia Medical Technologies.
February 28th
A neuromodulation company based in the USA.
April 6th
Participating in NEMO V with Garuda Therapeutics and Magnolia Medical Technologies.
December 11th
A neuromodulation company based in the USA.
2023
January 15th
Participating in NEMO V with Garuda Therapeutics and Magnolia Medical Technologies.
February 13th
Investment in shares.
May 22nd
Participation in the milestone closing of Series B-1 shares.
July 12th
A neuromodulation company based in the USA.
July 18th
Participating in NEMO V with Garuda Therapeutics and Magnolia Medical Technologies.
September 11th
Second tranch investment.
